Helius Secures HCPCS Codes for Portable Neuromodulation Stimulator

 Significant step toward reimbursement for the only medical device approved in the U.S. for treatment of gait deficit due to multiple sclerosis (“MS”) --

-- Proceeds from recent stock issuances through the Company’s At-The-Market (“ATM”) program extends cash runway into the third quarter 2024 --

https://www.globenewswire.com/news-release/2024/03/04/2839397/0/en/Helius-Medical-Technologies-Inc-Secures-HCPCS-Codes-for-Portable-Neuromodulation-Stimulator-PoNS-Mouthpiece-and-Controller.html